Press Releases
Janssen Healthcare Innovation two-time finalistsat eyeforpharma Barcelona Awards
Janssen Healthcare Innovation’s Care4Today programme is set to take two of the highest honours at the 2015 eyeforpharma Barcelona Awards as the shortlist was today...
Press Releases
Apps & Digital Resources vie for top honour at eyeforpharma Barcelona Awards
Two thirds of the finalists for the ‘Most Valuable Patient Initiative’ in the 2015 eyeforpharma Barcelona Awards have used interactive digital resources or mobile applications...
Press Releases
TxCell receives EU Orphan Drug Designation for Col-Treg in the treatment of non-infectious uveitis
TxCell SA (FR0010127662 – TXCL), a biotechnology company developing innovative, cost-effective, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory...
Press Releases
CARLINA Technologies signs a partnership agreement with Atlangram to develop controlled-release forms of antibiotics targeting osteoarticular diseases
Angers, France, December 16, 2014 - CARLINA Technologies, a biotechnology company specializing in the development of nanomedicines, today announces the signing of a partnership agreement...
Press Releases
Evotec and Sanofi negotiate drug discovery collaboration and pre-clinical development
Germany-based Evotec is negotiating with French drugmaker Sanofi for a multi-component strategic collaboration over the next five years. The alliance...
Press Releases
Mylan and Gilead partner for TAF-based HIV treatments in developing markets
Mylan Laboratories has signed an agreement with Gilead Sciences to increase access to Tenofovir Alafenamide (TAF) based HIV treatments in developing countries. ...
Press Releases
Daiichi and UCB Biopharma partner to introduce epilepsy treatment Lacosamide in Japan
Japan-based Daiichi Sankyo has signed an agreement with UCB Biopharma to jointly commercialise Lacosamide for the treatment of patients with epilepsy in Japan....
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.